EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Can a participant‐referred ‘study buddy’ increase retention of rural people who use drugs in research? A multi‐site, randomized trial

April M Young iD, Kathryn E Lancaster, Miriam R Elman, Sarann Bielavitz iD, Ryan R Cook iD, Angela T Estadt iD, Madison N Enderle, Edward Freeman, Jodi Lapidus, Philip T Korthuis iD

Addiction · 2025

DOI: 10.1111/add.70250 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2025. Verfasst von April M Young und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Environmental Health, University of Kentucky, Lexington, KY, USA. Hauptthemen laut MEDLINE: Rural Population, Substance Abuse, Intravenous, Patient Selection, Substance-Related Disorders. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDA NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To test the efficacy of a participant‐referred “study buddy” intervention compared with standard retention strategies in retaining rural people who use drugs (PWUD) in longitudinal research.

Design

Multi‐site, two‐arm, randomized controlled trial.

Setting

Rural counties in Ohio, Oregon, and Kentucky, USA.

Participants

People enrolled in the Peer‐based Retention Of people who Use Drugs in Rural Research (PROUD‐R 2 ) study who were 18 years or older, resided in the study area, and used opioids or injected any drug to get high in the past 30 days between August 2020 and August 2022.

Participants

(n = 739) were 42% female, mostly White (89%) and non‐Hispanic (96%), unstably housed (57%), and reported lifetime injection drug use (93%). The most common drugs of choice were methamphetamine (42%) and heroin (38%). Intervention and Comparator Participants were allocated (1:1, stratified by site), to: [1] standard retention approach involving appointment reminders and contact information updates by study staff (n = 365), or [2] the intervention arm, receiving the standard retention approach and asked to recruit a “study buddy” (n = 374). Study buddies were invited to view a training video and instructed to encourage their intervention participant to attend follow‐up appointments.

Measurements

Intervention, control, and study buddy participants completed interviewer‐administered surveys at baseline and at 6 and 12 months. Outcomes included retention at 12 months (primary) and 6 months (secondary).

Findings

Retention was 50.3% at 6 months and 46.1% at 12 months. Only 23.5% of intervention participants recruited a study buddy. In intent‐to‐treat analyses, the intervention did not increase retention at 12 (adjusted odds ratio [AOR] 1.08, 95% confidence interval [CI] 0.79–1.47) or 6 (AOR 0.96, 95% CI 0.69–1.34) months.

Conclusions

Recruitment of self‐identified “study buddies” did not appear to statistically significantly improve retention of rural people who use drugs in this longitudinal study at 6‐ and 12‐month follow‐up relative to standard retention approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rural PopulationSubstance Abuse, IntravenousPatient SelectionSubstance-Related DisordersHumansFemaleMaleAdultMiddle AgedKentuckyOhioOregonLongitudinal StudiesPeer GroupOpioid-Related DisordersYoung Adult

Stichwörter der Autor:innen

attritionclinical trialinjection drug useretentionruralsubstance usetrial design

Autor:innen und Institutionen

  • Department of Epidemiology and Environmental Health, University of Kentucky, Lexington, KY, USA.
  • Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA.
  • Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • School of Public Health, Oregon Health & Science University/Portland State University, Portland, OR, USA.
  • Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Division of Epidemiology, College of Public Health, Ohio State University, Columbus, OH, USA.

ORCID-Profile: April M Young, Sarann Bielavitz, Ryan R Cook, Angela T Estadt, Philip T Korthuis

Förderung

  • NCATS NIH HHS
  • NIDA NIH HHS
  • AHRQ HHS
  • Patient-Centered Outcomes Research Institute
  • National Center for Advancing Translational Sciences
  • National Institute on Drug Abuse

Zitieren

APA

Young, A. M., Lancaster, K. E., Elman, M. R., Bielavitz, S., Cook, R. R., Estadt, A. T., Enderle, M. N., Freeman, E., Lapidus, J., & Korthuis, P. T. (2025). Can a participant‐referred ‘study buddy’ increase retention of rural people who use drugs in research? A multi‐site, randomized trial. Addiction. https://doi.org/10.1111/add.70250

Vancouver

Young AM, Lancaster KE, Elman MR, Bielavitz S, Cook RR, Estadt AT, et al. Can a participant‐referred ‘study buddy’ increase retention of rural people who use drugs in research? A multi‐site, randomized trial. Addiction. 2025. doi:10.1111/add.70250

BibTeX
@article{Young2025,
  author = {Young, April M and Lancaster, Kathryn E and Elman, Miriam R and Bielavitz, Sarann and Cook, Ryan R and Estadt, Angela T and Enderle, Madison N and Freeman, Edward and Lapidus, Jodi and Korthuis, Philip T},
  title = {Can a participant‐referred ‘study buddy’ increase retention of rural people who use drugs in research? A multi‐site, randomized trial},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.70250}
}
Kostenlos starten →